STOCK TITAN

Vivani Medical director buys 33,169 and 85,265 shares

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Vivani Medical, Inc. (VANI) director and 10% owner Gregg Williams reported two open-market purchases of common stock: 33,169 shares at a weighted average $1.054 per share on November 18, 2026, and 85,265 shares at a weighted average $1.095 per share on November 19, 2026. The respective reported purchase-price ranges were $1.02–$1.07 and $1.06–$1.125. The transactions were reported as indirect holdings, and no Rule 10b5-1 plan is reported. Williams disclosed owning 41,910,499 shares directly and/or indirectly, including 4,799,200 shares owned directly.

Insider Williams Gregg
Role Director, 10% Owner
Bought 118,434 shs ($128K)
Type Security Shares Price Value
Purchase Common Stock F1, F4, F3 85,265 $1.095 $93K
Purchase Common Stock F1, F2, F3 33,169 $1.054 $35K
Holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 37,111,299 shares (Indirect, See footnote); Common Stock — 4,799,200 shares (Direct)
Footnotes (4)
  1. F1. Individual purchased shares on the open market.
  2. F2. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.02 to $1.07, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. F3. The reporting person owns 41,910,499 shares directly and/or indirectly as follows: (i) 4,799,200 shares of common stock owned by the reporting person, (ii) 34,985,547 shares of common stock owned by Gregg G. Williams 2006 Trust, (iii) 1,212,856 shares of common stock owned by Williams International Co. LLC, (iv) 181,587 shares of common stock owned by Sam Williams Family Investments LLC, and (v) 731,309 shares of common stock owned by Sam B. Williams 1995 Generation-Skipping Trust. Gregg Williams has voting and dispositive power over all of these shares.
  4. F4. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.06 to $1.125, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Shares purchased 33,169 shares Open-market purchase on November 18, 2026
Weighted-average purchase price $1.054 per share November 18, 2026 purchase; prices ranged from $1.02 to $1.07
Shares purchased 85,265 shares Open-market purchase on November 19, 2026
Weighted-average purchase price $1.095 per share November 19, 2026 purchase; prices ranged from $1.06 to $1.125
Direct shares owned 4,799,200 shares Shares owned by Gregg Williams, as disclosed in the ownership footnote
Direct and indirect shares owned 41,910,499 shares Total disclosed in the ownership footnote
weighted average price financial
"the November 18 and November 19 purchase prices"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Rule 10b5-1 plan regulatory
"the purchases reported without a Rule 10b5-1 plan"
A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many VANI shares did director Gregg Williams buy, and at what prices?

Gregg Williams reported open-market purchases of 33,169 shares on November 18, 2026, at a weighted average $1.054 per share and 85,265 shares on November 19, 2026, at a weighted average $1.095 per share. The respective purchase-price ranges were $1.02–$1.07 and $1.06–$1.125. No Rule 10b5-1 plan is reported.

How many Vivani Medical shares does Gregg Williams own?

Williams disclosed owning 41,910,499 shares directly and/or indirectly. The disclosed components included 4,799,200 shares owned directly, 34,985,547 held by Gregg G. Williams 2006 Trust, 1,212,856 by Williams International Co. LLC, 181,587 by Sam Williams Family Investments LLC, and 731,309 by Sam B. Williams 1995 Generation-Skipping Trust.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Williams Gregg

(Last)(First)(Middle)
C/O VIVANI MEDICAL, INC.
1350 S. LOOP ROAD

(Street)
ALAMEDA CALIFORNIA 94502

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Vivani Medical, Inc. [ VANI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirectorX10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/18/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock11/18/2026P(1)33,169A$1.054(2)37,026,034ISee footnote(3)
Common Stock11/19/2026P(1)85,265A$1.095(4)37,111,299ISee footnote(3)
Common Stock4,799,200D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Individual purchased shares on the open market.
2. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.02 to $1.07, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3. The reporting person owns 41,910,499 shares directly and/or indirectly as follows: (i) 4,799,200 shares of common stock owned by the reporting person, (ii) 34,985,547 shares of common stock owned by Gregg G. Williams 2006 Trust, (iii) 1,212,856 shares of common stock owned by Williams International Co. LLC, (iv) 181,587 shares of common stock owned by Sam Williams Family Investments LLC, and (v) 731,309 shares of common stock owned by Sam B. Williams 1995 Generation-Skipping Trust. Gregg Williams has voting and dispositive power over all of these shares.
4. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.06 to $1.125, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
/s/ Anthony Baldor, Attorney-in-fact11/20/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading